Stem cell treatment for children with bronchiolitis obliterans
Part of Lungs & breathing clinical trials.
This early trial tests if airway basal stem cells can help children with a serious lung condition called bronchiolitis obliterans. It aims to improve lung function and reduce the need for oxygen or breathing support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 28 days and 18 years old.
- Your child must have been diagnosed with bronchiolitis obliterans by a doctor.
- Your child must have severe lung problems, such as very low lung function (FEV1 less than 55% of normal) or need constant oxygen or a breathing machine.
- Your child must not have had any acute infections in the past month.
- Your child must be able to safely undergo a bronchoscopy (a procedure where a thin tube is put into the lungs to deliver cells).
- You and your child (if old enough) must agree to take part and follow all study visits and tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether umbilical cord stem cells can help premature babies with severe bronchopulmonary dysplasia (a chronic lung disease) who still need a breathing tube after standard hormone treatment. The goal is to see if it is safe and improves their lung condition.
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
This study checks new ways to measure breathing in children who had a stem cell transplant to better detect a lung condition called bronchiolitis obliterans syndrome. If you join, you’ll do breathing and imaging tests, and researchers will look for patterns that may help with diagnosis.
This trial tests if stem cells can help premature babies with severe lung disease (bronchopulmonary dysplasia). It is for very small, early-born babies who still need a breathing machine between 5 and 14 days after birth.
This study tests a new treatment made from small mobile stem cells, given by inhalation, for people with moderate to severe COPD caused by smoking or pollution. It aims to see if the treatment is safe and helps improve lung function.
This study collects tiny airway samples during a planned bronchoscopy to better understand bronchiolitis obliterans (a long-term lung complication after transplant). Your samples may help researchers learn how the disease starts and changes over time.
Hear when a new Pediatric Bronchiolitis Obliterans trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.